You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

LO/OVRAL-28 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lo/ovral-28 patents expire, and when can generic versions of Lo/ovral-28 launch?

Lo/ovral-28 is a drug marketed by Wyeth Pharms and is included in one NDA.

The generic ingredient in LO/OVRAL-28 is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.

US Patents and Regulatory Information for LO/OVRAL-28

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms LO/OVRAL-28 ethinyl estradiol; norgestrel TABLET;ORAL-28 017802-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LO/OVRAL-28

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms LO/OVRAL-28 ethinyl estradiol; norgestrel TABLET;ORAL-28 017802-001 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Wyeth Pharms LO/OVRAL-28 ethinyl estradiol; norgestrel TABLET;ORAL-28 017802-001 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Wyeth Pharms LO/OVRAL-28 ethinyl estradiol; norgestrel TABLET;ORAL-28 017802-001 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for LO/OVRAL-28

See the table below for patents covering LO/OVRAL-28 around the world.

Country Patent Number Title Estimated Expiration
Netherlands 6402399 ⤷  Try a Trial
Switzerland 565730 Steroid intermediates for total synthesis ⤷  Try a Trial
India 139095 PROCESS FOR PREPARING 13-ETHYLGON-4-ENES ⤷  Try a Trial
Switzerland 430706 Verfahren zur Herstellung von Steroiden ⤷  Try a Trial
Netherlands 6402300 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for LO/OVRAL-28

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0771217 CA 2006 00038 Denmark ⤷  Try a Trial PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
1214076 C01214076/01 Switzerland ⤷  Try a Trial PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
0398460 C300221 Netherlands ⤷  Try a Trial PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
1453521 122015000093 Germany ⤷  Try a Trial PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129
1453521 CA 2016 00016 Denmark ⤷  Try a Trial PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.